- Home
- TOPP vs CRIS Comparison
TOPP vs CRIS Comparison
Compare TOPP & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOPP
- CRIS
- Stock Information
- Founded
- TOPP 2014
- CRIS 2000
- Country
- TOPP United States
- CRIS United States
- Employees
- TOPP N/A
- CRIS N/A
- Industry
- TOPP
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TOPP
- CRIS Health Care
- Exchange
- TOPP NYSE
- CRIS Nasdaq
- Market Cap
- TOPP 26.6M
- CRIS 21.3M
- IPO Year
- TOPP 2025
- CRIS 2000
- Fundamental
- Price
- TOPP $1.70
- CRIS $2.27
- Analyst Decision
- TOPP
- CRIS Strong Buy
- Analyst Count
- TOPP 0
- CRIS 2
- Target Price
- TOPP N/A
- CRIS $16.50
- AVG Volume (30 Days)
- TOPP 11.8K
- CRIS 75.5K
- Earning Date
- TOPP 08-11-2025
- CRIS 07-31-2025
- Dividend Yield
- TOPP N/A
- CRIS N/A
- EPS Growth
- TOPP N/A
- CRIS N/A
- EPS
- TOPP N/A
- CRIS N/A
- Revenue
- TOPP $16,117,227.00
- CRIS $11,202,000.00
- Revenue This Year
- TOPP N/A
- CRIS N/A
- Revenue Next Year
- TOPP N/A
- CRIS $10.67
- P/E Ratio
- TOPP N/A
- CRIS N/A
- Revenue Growth
- TOPP 0.44
- CRIS 14.17
- 52 Week Low
- TOPP $0.97
- CRIS $1.02
- 52 Week High
- TOPP $4.50
- CRIS $8.29
- Technical
- Relative Strength Index (RSI)
- TOPP N/A
- CRIS 50.37
- Support Level
- TOPP N/A
- CRIS $2.11
- Resistance Level
- TOPP N/A
- CRIS $2.26
- Average True Range (ATR)
- TOPP 0.00
- CRIS 0.20
- MACD
- TOPP 0.00
- CRIS -0.04
- Stochastic Oscillator
- TOPP 0.00
- CRIS 16.85
About TOPP TOPPOINT HOLDINGS INC
Toppoint Holdings Inc is a truckload services and solutions provider focused on the recycling export supply chain. The company operates in one operating segment where it derives its revenues from the delivery of truckload services.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.